Neurology News

Despite a mounting number of state-level laws enacted to protect vulnerable patients against step therapy protocols, without official enforcement, these laws safeguard less than 10% of patients, according to data published in Health Economics Policy and Law.

The AMA adopted a policy it hopes will enhance the diversity of the physician workforce, according to a press release.

The FDA granted breakthrough therapy designation for two investigational antibody therapies in Alzheimer’s disease. Lecanemab is an anti-amyloid beta protofibril antibody and donanemab targets N3pG, a modified form of beta amyloid.

The Team Physician Consensus Conference released a new guidance document to help team physicians manage sport-related concussions in athletes of all ages.

Tai chi may have the potential to reduce symptoms of depression, anxiety and stress, as well as improve sleep, for stroke survivors, according to a small feasibility study presented at EuroHeartCare.

June is Alzheimer’s and Brain Awareness Month, an observance recognized each year by the CDC and other organizations to raise awareness of Alzheimer’s disease and other dementias.

Repeated attempts to retrieve a clot in patients with acute stroke increased both the rate of emboli to new territory and infarct growth volume, with an impact on functional outcomes even when recanalization was successful.

Gantenerumab decreased molecular markers of disease, but did not demonstrate a cognitive benefit, in patients with dominantly inherited Alzheimer’s disease, according to results from a phase 2/3 trial.

Penumbra announced it received FDA 510(k) clearance for its reperfusion catheter system designed to help clinicians navigate complex distal vessel anatomy in large vessel occlusion acute ischemic stroke.

CMS recently proposed a rule that aims to strengthen the U.S. health care workforce.